![Douglas Hughes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Hughes
Direktor/Vorstandsmitglied bei
IMMUNOVANT, INC.
Vermögen: 4 Mio $ am 31.05.2026
Profil
Douglas Hughes is currently Director at Immunovant Sciences Ltd. since 2019, Independent Director at Immunovant, Inc. since 2019, Chief Financial Officer & Director at Calyxo, Inc. since 2018, and Chief Financial Officer at Calyxo USA, Inc. since 2019.
Former roles include Director-Investor Relations at The Clorox Co., Independent Non-Executive Director at Eargo, Inc. from 2020 to 2022, Director at Immunovant, Inc., Vice President-Investor Relations at Guidant Corp., Vice President-Finance & Administration at Boston Scientific Corp., Chief Operating & Financial Officer at Nellix, Inc. from 2010 to 2011, Chief Financial Officer at NeoTract, Inc. from 2011 to 2018, Chief Financial Officer at Evalve, Inc. from 2009 to 2010, and Chief Financial Officer at Maquet.
Education includes an MBA from The University of Chicago and undergraduate studies at San Francisco State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOVANT INC 0,07 % | 07.04.2026 | 134.653 ( 0,07 % ) | 4 Mio $ | 31.05.2026 |
Aktive Positionen von Douglas Hughes
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOVANT, INC. | Direktor/Vorstandsmitglied | 18.12.2019 |
Calyxo USA, Inc.
 Calyxo USA, Inc. Engineering & ConstructionIndustrial Services Develops solar energy | Finanzdirektor/CFO | 01.01.2019 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Direktor/Vorstandsmitglied | 01.10.2019 |
Calyxo, Inc.
 Calyxo, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for kidney stone disease treatment | Finanzdirektor/CFO | 01.01.2018 |
Ehemalige bekannte Positionen von Douglas Hughes
| Unternehmen | Position | Ende |
|---|---|---|
| EARGO, INC. | Direktor/Vorstandsmitglied | 07.12.2022 |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology Develops surgical devices for urological and gynecological disorders | Finanzdirektor/CFO | 01.01.2018 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Public Communications Contact | 01.04.2011 |
Nellix, Inc.
 Nellix, Inc. Medical SpecialtiesHealth Technology Develops novel solutions to vascular diseases | Finanzdirektor/CFO | 01.01.2011 |
Evalve, Inc.
 Evalve, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices | Finanzdirektor/CFO | 01.01.2010 |
Ausbildung von Douglas Hughes
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
The Clorox Co.
 The Clorox Co. Household/Personal CareConsumer Non-Durables Manufactures and markets cleaning, disinfection, bags, wraps, food & cat litter products | Consumer Non-Durables |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Nellix, Inc.
Nellix, Inc. Medical SpecialtiesHealth Technology Develops novel solutions to vascular diseases | Health Technology |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology Develops surgical devices for urological and gynecological disorders | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evalve, Inc.
Evalve, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices | Health Technology |
Maquet
 Maquet Medical DistributorsDistribution Services Wholesales medical equipment | Distribution Services |
Calyxo USA, Inc.
Calyxo USA, Inc. Engineering & ConstructionIndustrial Services Develops solar energy | Industrial Services |
Eargo, Inc.
 Eargo, Inc. Medical SpecialtiesHealth Technology Designs and manufactures hearing aids | Health Technology |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for kidney stone disease treatment | Health Technology |
